BOLD functional MRI in disease and pharmacological studies: room for improvement?

Magnetic Resonance Imaging

Volumn 25, Issue 6, 2007, Pages 978-988

  Iannetti, G D ^a   Wise, Richard G ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Blood oxygen level dependent contrast (BOLD); Disease; Electroencephalography (EEG); Functional magnetic resonance imaging (fMRI); Pharmacological fMRI; Physiological confounds

Indexed keywords

BLOOD OXYGENATION LEVEL DEPENDENT FUNCTIONAL MAGNETIC RESONANCE IMAGING; BRAIN BLOOD VOLUME; BRAIN PERFUSION; BRAIN TUMOR; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTROENCEPHALOGRAPHY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEART FUNCTION TEST; HUMAN; MEASUREMENT; MULTIPLE SCLEROSIS; NERVE CELL; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REVIEW; SIGNAL NOISE RATIO; SIGNAL TRANSDUCTION; STROKE; TASK PERFORMANCE;

ANIMALS; BLOOD VOLUME; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; ELECTROENCEPHALOGRAPHY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETOENCEPHALOGRAPHY; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEURONS; OXYGEN; TECHNOLOGY, PHARMACEUTICAL;

ANIMALIA;

EID: 34447553331     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2007.03.018     Document Type: Review

References (65)

1. Kwong K.K., Belliveau J.W., Chesler D.A., Goldberg I.E., Weisskoff R.M., Poncelet B.P., et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A 89 12 (1992) 5675-5679
2. Ogawa S., Lee T.M., Kay A.R., and Tank D.W. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 87 24 (1990) 9868-9872
3. Matthews P.M., Honey G.D., and Bullmore E.T. Applications of fMRI in translational medicine and clinical practice. Nat Rev Neurosci 7 9 (2006) 732-744
4. Wise R.G., and Tracey I. The role of fMRI in drug discovery. J Magn Reson Imaging 23 6 (2006) 862-876
5. Arthurs O.J., and Boniface S. How well do we understand the neural origins of the fMRI BOLD signal?. Trends Neurosci 25 1 (2002) 27-31
6. Logothetis N.K., Pauls J., Augath M., Trinath T., and Oeltermann A. Neurophysiological investigation of the basis of the fMRI signal. Nature 412 6843 (2001) 150-157
7. Logothetis N.K., and Pfeuffer J. On the nature of the BOLD fMRI contrast mechanism. Magn Reson Imaging 22 10 (2004) 1517-1531
8. Nair D.G. About being BOLD. Brain Res Brain Res Rev 50 2 (2005) 229-243
9. Hyder F., Rothman D.L., and Shulman R.G. Total neuroenergetics support localized brain activity: implications for the interpretation of fMRI. Proc Natl Acad Sci U S A 99 16 (2002) 10771-10776
10. Greicius M.D., Srivastava G., Reiss A.L., and Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A 101 13 (2004) 4637-4642
11. Magistretti P.J., and Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B Biol Sci 354 1387 (1999) 1155-1163
12. Magistretti P.J., Pellerin L., Rothman D.L., and Shulman R.G. Energy on demand. Science 283 5401 (1999) 496-497
13. Attwell D., and Iadecola C. The neural basis of functional brain imaging signals. Trends Neurosci 25 12 (2002) 621-625
14. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5 5 (2004) 347-360
15. Posse S., Kemna L.J., Elghahwagi B., Wiese S., and Kiselev V.G. Effect of graded hypo- and hypercapnia on fMRI contrast in visual cortex: quantification of T(*)(2) changes by multiecho EPI. Magn Reson Med 46 2 (2001) 264-271
16. Cohen E.R., Ugurbil K., and Kim S.G. Effect of basal conditions on the magnitude and dynamics of the blood oxygenation level-dependent fMRI response. J Cereb Blood Flow Metab 22 9 (2002) 1042-1053
17. Brown G.G., Eyler L., Zorrilla T., Georgy B., Kindermann S.S., Wong E.C., et al. BOLD and perfusion response to finger-thumb apposition after acetazolamide administration: differential relationship to global perfusion. J Cereb Blood Flow Metab 23 7 (2003) 829-837
18. Buxton R.B., Uludag K., Dubowitz D.J., and Liu T.T. Modeling the hemodynamic response to brain activation. NeuroImage 23 Suppl 1 (2004) S220-S233
19. Tuunanen P.I., and Kauppinen R.A. Effects of oxygen saturation on BOLD and arterial spin labelling perfusion fMRI signals studied in a motor activation task. NeuroImage 30 1 (2006) 102-109
20. Kemna L.J., Kiselev V.G., and Posse S. Changes of the HRF during hypoxia and hyperoxia measured with event-related BOLD contrast fMRI. NeuroImage 13 6 (2001) S991
21. Kalisch R., Elbel G.K., Gossl C., Czisch M., and Auer D.P. Blood pressure changes induced by arterial blood withdrawal influence bold signal in anesthesized rats at 7 Tesla: implications for pharmacologic MRI. NeuroImage 14 4 (2001) 891-898
22. Buxton R.B. An introduction to functional magnetic resonance imaging: principles and techniques (2002), Cambridge University Press, Cambridge
23. Davis T.L., Kwong K.K., Weisskoff R.M., and Rosen B.R. Calibrated functional MRI: mapping the dynamics of oxidative metabolism. Proc Natl Acad Sci U S A 95 4 (1998) 1834-1839
24. Hoge R.D., Atkinson J., Gill B., Crelier G.R., Marrett S., and Pike G.B. Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: the deoxyhemoglobin dilution model. Magn Reson Med 42 5 (1999) 849-863
25. Hoge R.D., Atkinson J., Gill B., Crelier G.R., Marrett S., and Pike G.B. Linear coupling between cerebral blood flow and oxygen consumption in activated human cortex. Proc Natl Acad Sci U S A 96 16 (1999) 9403-9408
26. Reddy H., Narayanan S., Arnoutelis R., Jenkinson M., Antel J., Matthews P.M., et al. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. Brain 123 Pt 11 (2000) 2314-2320
27. Pantano P., Iannetti G.D., Caramia F., Mainero C., Di Legge S.L., Bozzao L., et al. Cortical motor reorganization after a single clinical attack of multiple sclerosis. Brain 125 Pt 7 (2002) 1607-1615
28. Loubinoux I., Carel C., Pariente J., Dechaumont S., Albucher J.F., Marque P., et al. Correlation between cerebral reorganization and motor recovery after subcortical infarcts. NeuroImage 20 4 (2003) 2166-2180
29. Cao Y., D'Olhaberriague L., Vikingstad E.M., Levine S.R., and Welch K.M. Pilot study of functional MRI to assess cerebral activation of motor function after poststroke hemiparesis. Stroke 29 1 (1998) 112-122
30. Wise R.G., Rogers R., Painter D., Bantick S., Ploghaus A., Williams P., et al. Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil. NeuroImage 16 4 (2002) 999-1014
31. Iannetti G.D., Zambreanu L., Wise R.G., Buchanan T.J., Huggins J.P., Smart T.S., et al. Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. Proc Natl Acad Sci U S A 102 50 (2005) 18195-18200
32. Pattinson K.T., Rogers R., Mayhew S.D., Tracey I., and Wise R.G. Pharmacological FMRI: measuring opioid effects on the BOLD response to hypercapnia. J Cereb Blood Flow Metab 27 2 (2007) 414-423
33. Bloom A.S., Hoffmann R.G., Fuller S.A., Pankiewicz J., Harsch H.H., and Stein E.A. Determination of drug-induced changes in functional MRI signal using a pharmacokinetic model. Hum Brain Mapp 8 4 (1999) 235-244
34. Schlaug G., Benfield A., Baird A.E., Siewert B., Lovblad K.O., Parker R.A., et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 53 7 (1999) 1528-1537
35. Fujiwara N., Sakatani K., Katayama Y., Murata Y., Hoshino T., Fukaya C., et al. Evoked-cerebral blood oxygenation changes in false-negative activations in BOLD contrast functional MRI of patients with brain tumors. NeuroImage 21 4 (2004) 1464-1471
36. Ge Y., Law M., Johnson G., Herbert J., Babb J.S., Mannon L.J., et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. Am J Neuroradiol 26 6 (2005) 1539-1547
37. Murata Y., Sakatani K., Hoshino T., Fujiwara N., Kano T., Nakamura S., et al. Effects of cerebral ischemia on evoked cerebral blood oxygenation responses and BOLD contrast functional MRI in stroke patients. Stroke 37 10 (2006) 2514-2520
38. Rashid W., Parkes L.M., Ingle G.T., Chard D.T., Toosy A.T., Altmann D.R., et al. Abnormalities of cerebral perfusion in multiple sclerosis. J Neurol Neurosurg Psychiatry 75 9 (2004) 1288-1293
39. Smith S.M. Overview of fMRI analysis. In: Jezzard P., Matthews P.M., and Smith S.M. (Eds). Functional MRI: an introduction to methods. 1st ed. (2001), Oxford University Press, Oxford 213-228
40. Bendlin B.B., Trouard T.P., and Ryan L. Caffeine attenuates practice effects in word stem completion as measured by fMRI BOLD signal. Hum Brain Mapp (2006) Nov 8 [Epub ahead of print]
41. Luh W.M., Wong E.C., Bandettini P.A., Ward B.D., and Hyde J.S. Comparison of simultaneously measured perfusion and BOLD signal increases during brain activation with T(1)-based tissue identification. Magn Reson Med 44 1 (2000) 137-143
42. Schulte A.C., Speck O., Oesterle C., and Hennig J. Separation and quantification of perfusion and BOLD effects by simultaneous acquisition of functional I(0)- and T2(*)-parameter maps. Magn Reson Med 45 5 (2001) 811-816
43. Kim J., Whyte J., Wang J., Rao H., Tang K.Z., and Detre J.A. Continuous ASL perfusion fMRI investigation of higher cognition: quantification of tonic CBF changes during sustained attention and working memory tasks. NeuroImage 31 1 (2006) 376-385
44. van der Zande F.H., Hofman P.A., and Backes W.H. Mapping hypercapnia-induced cerebrovascular reactivity using BOLD MRI. Neuroradiology 47 2 (2005) 114-120
45. Rostrup E., Law I., Blinkenberg M., Larsson H.B., Born A.P., Holm S., et al. Regional differences in the CBF and BOLD responses to hypercapnia: a combined PET and fMRI study. NeuroImage 11 2 (2000) 87-97
46. Mukherjee B., Preece M., Houston G.C., Papadakis N.G., Carpenter T.A., Hall L.D., et al. Mapping of the cerebral response to acetazolamide using graded asymmetric spin echo EPI. Magn Reson Imaging 23 9 (2005) 907-920
47. Bandettini P.A., and Wong E.C. A hypercapnia-based normalization method for improved spatial localization of human brain activation with fMRI. NMR Biomed 10 4-5 (1997) 197-203
48. Kemna L.J., and Posse S. Effect of respiratory CO(2) changes on the temporal dynamics of the hemodynamic response in functional MR imaging. NeuroImage 14 3 (2001) 642-649
49. Mitsis G.D., Ainslie P.N., Poulin M.J., Robbins P.A., and Marmarelis V.Z. Nonlinear modeling of the dynamic effects of arterial pressure and blood gas variations on cerebral blood flow in healthy humans. Adv Exp Med Biol 551 (2004) 259-265
50. Donahue M.J., Lu H., Jones C.K., Edden R.A., Pekar J.J., and van Zijl P.C. Theoretical and experimental investigation of the VASO contrast mechanism. Magn Reson Med 56 6 (2006) 1261-1273
51. St Lawrence K.S., Ye F.Q., Lewis B.K., Frank J.A., and McLaughlin A.C. Measuring the effects of indomethacin on changes in cerebral oxidative metabolism and cerebral blood flow during sensorimotor activation. Magn Reson Med 50 1 (2003) 99-106
52. Arthurs O.J., Williams E.J., Carpenter T.A., Pickard J.D., and Boniface S.J. Linear coupling between functional magnetic resonance imaging and evoked potential amplitude in human somatosensory cortex. Neuroscience 101 4 (2000) 803-806
53. Bandettini P.A., Kwong K.K., Davis T.L., Tootell R.B., Wong E.C., Fox P.T., et al. Characterization of cerebral blood oxygenation and flow changes during prolonged brain activation. Hum Brain Mapp 5 2 (1997) 93-109
54. Niazy R.K., Beckmann C.F., Iannetti G.D., Brady J.M., and Smith S.M. Removal of FMRI environment artifacts from EEG data using optimal basis sets. NeuroImage 28 3 (2005) 720-737
55. Iannetti G.D., Niazy R.K., Wise R.G., Jezzard P., Brooks J.C., Zambreanu L., et al. Simultaneous recording of laser-evoked brain potentials and continuous, high-field functional magnetic resonance imaging in humans. NeuroImage 28 3 (2005) 708-719
56. Lemieux L., Salek-Haddadi A., Josephs O., Allen P., Toms N., Scott C., et al. Event-related fMRI with simultaneous and continuous EEG: description of the method and initial case report. NeuroImage 14 3 (2001) 780-787
57. Iannetti G.D., Di Bonaventura C., Pantano P., Giallonardo A.T., Romanelli P.L., Bozzao L., et al. fMRI/EEG in paroxysmal activity elicited by elimination of central vision and fixation. Neurology 58 6 (2002) 976-979
58. Goldman R.I., Stern J.M., Engel Jr. J., and Cohen M.S. Simultaneous EEG and fMRI of the alpha rhythm. NeuroReport 13 18 (2002) 2487-2492
59. Laufs H., Kleinschmidt A., Beyerle A., Eger E., Salek-Haddadi A., Preibisch C., et al. EEG-correlated fMRI of human alpha activity. NeuroImage 19 4 (2003) 1463-1476
60. Debener S., Ullsperger M., Siegel M., Fiehler K., von Cramon D.Y., and Engel A.K. Trial-by-trial coupling of concurrent electroencephalogram and functional magnetic resonance imaging identifies the dynamics of performance monitoring. J Neurosci 25 50 (2005) 11730-11737
61. Rogers R., Wise R.G., Painter D.J., Longe S.E., and Tracey I. An investigation to dissociate the analgesic and anesthetic properties of ketamine using functional magnetic resonance imaging. Anesthesiology 100 2 (2004) 292-301
62. Frank L.R., Buxton R.B., and Wong E.C. Estimation of respiration-induced noise fluctuations from undersampled multislice fMRI data. Magn Reson Med 45 4 (2001) 635-644
63. Wise R.G., Ide K., Poulin M.J., and Tracey I. Resting fluctuations in arterial carbon dioxide induce significant low frequency variations in BOLD signal. NeuroImage 21 4 (2004) 1652-1664
64. Birn R.M., Diamond J.B., Smith M.A., and Bandettini P.A. Separating respiratory-variation-related fluctuations from neuronal-activity-related fluctuations in fMRI. NeuroImage 31 4 (2006) 1536-1548
65. Glover G.H., Li T.Q., and Ress D. Image-based method for retrospective correction of physiological motion effects in fMRI: RETROICOR. Magn Reson Med 44 1 (2000) 162-167